Private label medical product manufacturer Nuance Medical has acquired medical-grade silicone gel scar treatment brand BioCorneum, which was previously owned by Sientra. Terms of the transaction were not disclosed.
BioCorneum has now been folded into Nuance Medical’s Biodermis portfolio of silicone scar management products.
“Bringing BioCorneum into the Biodermis family marks a significant step in our journey to lead with innovative and impactful treatments in scar management,” said Mark Steele, president of Nuance Medical. “This acquisition integrates BioCorneum’s strong presence in the professional healthcare sector with Biodermis’ comprehensive range of silicone scar management products. We are excited about the combined capabilities this brings and the enhanced benefits it offers to our health care partners and their patients.”
